Abbott Laboratories
ABTAbbott Laboratories (ABT) is a Healthcare company that currently yields 2.88% — historically undervalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $110.69 and the overvaluation threshold at $165.13. Abbott Laboratories holds a quality score of 69/100 (Good), reflecting 9 consecutive years of dividend growth with a 67% payout ratio. The 5-year dividend CAGR stands at 10.4%.
ABT Dividend Yield History — Weiss Valuation
Why Now?
Abbott Laboratories is trading near its historical undervaluation band.
Current yield 2.9% vs historical max 2.2% (131% of maximum).
9 years of uninterrupted dividends.
Reasonable payout ratio of 67%.
ABT Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$318
Year 10 Income
$1,188
Yield on Cost
12.8%
Total Income
$6,530
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
ABT Dividend Quality Score
Quality Score
Good
Key Metrics
In-depth analysis
→ ABT Dividend Analysis ArticleCollections